Skip to main content

Radical cystectomy - bladder cancer surgery, done at high volume.

Removal of the bladder for muscle-invasive and high-risk disease - open or robotic, with ileal conduit, neobladder or Indiana pouch reconstruction. A high-volume consultant urologist, neoadjuvant chemotherapy where it earns its place, and an ERAS recovery pathway.

See indicative pricing
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What a private radical cystectomy costs in the UK.

Indicative ranges across our partner uro-oncology units.

In short

£32,000–£48,000, home in 6–9 nights.

Procedure Indicative range
Open radical cystectomy with ileal conduit £25,000–£38,000
Robotic radical cystectomy with intracorporeal ileal conduit £32,000–£48,000
Cystectomy with orthotopic neobladder £38,000–£55,000
Cystectomy with Indiana / continent cutaneous pouch £40,000–£55,000
Salvage cystectomy after radiotherapy £35,000–£55,000
Pelvic exenteration (extended resection) £45,000–£75,000
Uro-oncology consultation only £300–£500

Prices vary by hospital, by consultant, by approach (open vs robotic), by diversion (conduit, neobladder, pouch) and by ITU/HDU time. Neoadjuvant chemotherapy is itemised separately.

The problem

The right surgeon, the right diversion, and the chemotherapy conversation up front.

Cystectomy outcomes are strongly volume-dependent. We fix three things private uro-oncology can get wrong: surgeon volume, diversion choice, and whether neoadjuvant chemotherapy is properly offered.

  • Volume, not brochure

    Cystectomy outcomes are measurably better in high-volume centres. We only refer to surgeons whose annual numbers clear BAUS thresholds and whose complication rates are tracked.

  • Every diversion on the table

    Ileal conduit, neobladder or Indiana pouch - each with honest continence, follow-up and reoperation data. Not just whichever the surgeon prefers to build.

  • Neoadjuvant chemotherapy properly offered

    The 5–8 percent survival benefit of neoadjuvant cisplatin-based chemotherapy is real. If you are fit, it should be discussed - not quietly skipped to get to theatre faster.

When it helps

When radical cystectomy is the right step.

The situations we see most, plus the one red flag that means urgent two-week-wait haematuria clinic - not a routine GP appointment.

  • Muscle-invasive bladder cancer (T2–T4)

    The standard curative treatment for cT2–T4a urothelial carcinoma without distant spread, ideally after neoadjuvant cisplatin-based chemotherapy in fit patients.

  • High-risk non-muscle-invasive disease

    BCG-unresponsive or high-grade T1 disease with high-risk features - cystectomy is often the safer curative option over further intravesical therapy.

  • Variant histology

    Micropapillary, plasmacytoid, sarcomatoid, small-cell and squamous variants behave aggressively - early cystectomy is often recommended even at lower stages.

  • Refractory or symptomatic non-functioning bladder

    Severe radiation cystitis, intractable haemorrhagic cystitis, or a contracted painful bladder unresponsive to conservative treatment.

  • Salvage after failed radiotherapy or trimodality therapy

    Persistent or recurrent muscle-invasive disease after bladder-preserving radiotherapy or chemoradiotherapy.

  • Locally advanced pelvic malignancy involving bladder

    Selected gynaecological, colorectal or prostate cancers extending into the bladder may be managed by exenterative surgery with cystectomy.

  • Urachal and rare bladder tumours

    Urachal adenocarcinoma and selected pure adenocarcinomas of the bladder - partial or radical cystectomy is often the definitive treatment.

  • Red flag: painless visible haematuria

    Any visible blood in the urine in an adult over 45 needs an urgent two-week-wait haematuria clinic - flexible cystoscopy and CT urogram, not a routine GP appointment.

Surgical options

Approach and diversion - two separate choices.

What each option involves - the approach (open, robotic, laparoscopic) and the urinary diversion built (conduit, neobladder, continent pouch).

  • Open radical cystectomy

    The historic standard. A lower midline incision, direct visualisation, faster operative time. Still preferred for very locally advanced tumours or extensive prior pelvic surgery.

  • Robotic-assisted radical cystectomy

    Da Vinci platform, small ports, magnified 3D vision. Modern iRARC (intracorporeal reconstruction) means the diversion is also built inside - less blood loss, comparable oncological outcomes in trial data.

  • Laparoscopic radical cystectomy

    The middle ground - smaller incisions than open, less kit than robotic. Uncommon in the UK now; most minimally invasive cystectomy is robotic.

  • Ileal conduit (Bricker)

    A short segment of ileum makes a spout on the abdomen; urine drains continuously into a stoma bag. Simple, well established, lowest reoperation rate. The default choice for many.

  • Orthotopic neobladder

    A pouch built from ileum, anastomosed to the urethra. Voiding by relaxing the pelvic floor and straining. Continence takes months, night-time leakage common. Body image benefit, higher reoperation rate.

  • Indiana / continent cutaneous pouch

    An internal pouch (ileum plus caecum) drained by intermittent self-catheterisation through a small continent stoma. No external bag; requires committed self-catheterisation and irrigation.

  • Ureterosigmoidostomy (rare, historical)

    Ureters implanted into the sigmoid colon. Largely abandoned in modern practice because of long-term secondary cancer and metabolic risk. Mentioned for completeness.

  • Extended pelvic lymph node dissection

    Standard alongside cystectomy - up to and including the common iliac and pre-sacral nodes. Extends operative time but is prognostic and often therapeutic.

Safety and recovery

What to expect afterwards - honestly.

Cystectomy is one of the largest operations in urology. Complications are common but usually manageable in a high-volume centre with a proper ERAS pathway and specialist nursing.

  • It is major surgery

    Cystectomy is one of the largest operations in urology. 30-day mortality is roughly 1–3 percent in high-volume centres, 90-day complications occur in 40–60 percent - most are minor and managed on the ward.

  • Bleeding and transfusion

    Blood loss is meaningful, especially with open surgery. Group and save, cross-match availability, and transfusion in 10–30 percent depending on approach and centre.

  • Infection and wound complications

    Wound infection, deep pelvic collection and urinary infection are the commonest issues. Antibiotic prophylaxis, early mobilisation and stoma care all reduce risk.

  • Ileus and bowel complications

    Delayed bowel function is common after opening the abdomen and using bowel for diversion. Anastomotic leak of the ileo-ileal join occurs in 2–5 percent. ERAS pathways shorten ileus.

  • DVT and PE

    Pelvic surgery plus cancer is a high VTE risk. Chemical prophylaxis is continued for four weeks after discharge. Report calf pain, swelling or breathlessness urgently.

  • Sexual and reproductive impact

    Men: erectile dysfunction common due to neurovascular bundle disruption; ejaculation lost. Women: shortened or narrowed vagina depending on extent, potential ovarian removal. Nerve-sparing where oncologically safe.

  • Diversion-specific issues

    Ileal conduit: parastomal hernia, stoma stenosis. Neobladder: incontinence (especially nocturnal), self-catheterisation in 5–20 percent, mucus. Pouch: pouch stones, mucus, need for regular irrigation.

  • Metabolic and renal effects

    All diversions using bowel cause some acid-base disturbance and vitamin B12 malabsorption long-term. Annual bloods, B12 monitoring and renal-function surveillance are part of aftercare.

  • Red flags after discharge

    Fever above 38 °C, cloudy or foul urine, spreading redness, sudden severe abdominal pain, shortness of breath or calf pain need the same-day team or A&E, not a routine call.

Reading your operation note

Your operation note in four parts. Read the last one first.

Whichever approach and diversion were used, the note the urologist and pathologist send you keeps to the same shape.

A UK consultant urologist reviewing a patient’s cystectomy pathology

A quiet reminder

Surgical and pathological language is precise and can read coldly - we translate it for you.

If you would like us to talk you through the pathology, node yield and surveillance plan before your review, just ask.

  1. 01 Header

    Approach and diversion

    Open or robotic, extent of dissection, and the urinary diversion built (ileal conduit, neobladder, Indiana pouch, cutaneous ureterostomy). This defines what your daily life will look like.

  2. 02 Findings

    Tumour stage and margins

    Pathological T and N stage on the AJCC system, lymphovascular invasion, urethral and ureteric margins, presence of carcinoma in situ. This drives adjuvant treatment decisions.

  3. 03 Nodes

    Lymph node yield and positivity

    Total number of nodes removed (target 15+ in extended dissection) and how many were positive. Yield reflects the quality of the dissection.

  4. 04 Assessment

    Adjuvant plan and surveillance

    Read this first: adjuvant chemotherapy or immunotherapy if indicated, CT and cystoscopy surveillance schedule, and the specialist follow-up plan for your diversion.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Radical cystectomy is covered under a full cancer benefit when medically indicated. Robotic surcharge, ITU/HDU time and neoadjuvant chemotherapy typically need pre-authorisation.

Frequently asked

Everything we get asked about radical cystectomy.

Quick answers on open vs robotic, diversion choice, chemotherapy, recovery and cost.

  • Open or robotic cystectomy - does it matter?

    Trial data (iROC, RAZOR) show comparable oncological outcomes at 2–3 years. Robotic surgery - especially with intracorporeal reconstruction - reduces blood loss, transfusion and wound complications, and hospital stay is a day or two shorter. Open remains preferable for very locally advanced disease, extensive prior pelvic surgery or where a suitable robotic surgeon is not available. Surgeon experience with the specific approach matters more than the platform.

  • Ileal conduit vs neobladder vs Indiana pouch - how do I choose?

    Ileal conduit is the most reliable and lowest maintenance - an external bag, simple stoma care, lowest reoperation rate. Neobladder gives near-natural voiding but takes months of continence training, nocturnal leakage is common, and 5–20 percent need to self-catheterise. Indiana pouch avoids the external bag but requires committed self-catheterisation every 4–6 hours and pouch irrigation. Anatomy, tumour position, kidney function, dexterity, lifestyle and personal preference all count. We discuss all three before consent.

  • Will I need chemotherapy as well?

    For most fit patients with muscle-invasive disease, four cycles of cisplatin-based neoadjuvant chemotherapy before surgery improves overall survival by roughly 5–8 percent absolute - the standard of care where fitness and kidney function allow. Adjuvant immunotherapy with nivolumab is offered for high-risk pathology (ypT2+ or N+) after cystectomy in selected patients.

  • How long is recovery?

    Hospital stay 7–10 nights (a day or two less with robotic). Back to office work at 6–8 weeks, full activity and heavy lifting at 12 weeks. Neobladder continence takes 6–12 months to develop, especially at night. Stoma bag and pouch skills are usually confident within 2–4 weeks with specialist nurse input.

  • What are the alternatives to cystectomy?

    Bladder-preserving trimodality therapy - maximal TURBT, chemotherapy and radiotherapy - is an alternative for selected patients with cT2 disease, especially those unfit for surgery or who decline it. Outcomes in carefully selected cases are similar; the trade-off is lifelong intensive cystoscopic surveillance and the risk of salvage cystectomy later. We discuss both options honestly.

  • How much does a private radical cystectomy cost in the UK?

    Roughly £25,000–£38,000 for open cystectomy with ileal conduit, £32,000–£48,000 for robotic with intracorporeal conduit, £38,000–£55,000 with neobladder, and £40,000–£55,000 with Indiana pouch. Salvage cystectomy after radiotherapy and pelvic exenteration cost more. Neoadjuvant chemotherapy, hospital stay, ITU/HDU time and stoma nurse follow-up are usually itemised separately.

Related treatments

Looking for something else?